A screening method for the ALK fusion gene in NSCLC

A screening method for the ALK fusion gene in NSCLC

Lung cancer research has recently made significant progress in understanding the molecular pathogenesis and even the treatment of lung cancer. Such achievements are directly utilized in clinical practice. Indeed, the EML4-ALK fusion in non-small cell lung cancer (NSCLC) was first described in 2007,...

Full description

Bibliographic Details
Main Authors: Yoshiko eMurakami, Tetsuya eMitsudomi, Yasushi eYatabe
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-03-01
Series:Frontiers in Oncology
Subjects:
Immunohistochemistry
fish
RT-PCR
Anaplastic large cell lymphoma kinase
Molecular targeted drug
Non-small cell lung cancer
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00024/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00024/full

Similar Items